STOCK TITAN
  1. Home
  2. Sec-filings
  3. TGEN
  4. [8-K] TECOGEN INC. Reports Material Event

Tecogen (TGEN) grants new executive stock awards and raises base salaries

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Tecogen Inc. approved new equity awards and salary increases for its chief executive and other named executive officers. On June 26, 2026, the Board granted restricted stock and incentive stock options under the 2022 Stock Incentive Plan, including to CEO Abinand Rangesh, who received 174,081 shares of restricted stock and options on 26,041 shares. The awards vest in four equal annual installments and the options are exercisable at $5.17 per share. The Board also raised Mr. Rangesh’s annual base salary by 5% to $220,500, and increased base salaries for the other named officers by 3%, with new annual salaries ranging from $152,260 to $206,000.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
CEO restricted stock 174,081 shares Restricted stock award to CEO Abinand Rangesh
CEO stock options 26,041 shares Incentive stock options to CEO, vesting over four years
Option exercise price $5.17 per share Exercise price of incentive stock options
CEO base salary $220,500 Annual base salary after 5% increase
President & COO salary $206,000 Annual base salary after 3% increase
CFO salary $185,400 Annual base salary after 3% increase
VP Business Development salary $152,260 Annual base salary after 3% increase
General Counsel salary $185,400 Annual base salary after 3% increase
restricted stock financial
"the Company grant to them the following awards of restricted stock and incentive stock options"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
incentive stock options financial
"awards of restricted stock and incentive stock options pursuant to the Company’s 2022 Stock Incentive Plan"
Incentive stock options are a type of employee stock option that gives eligible workers the right to buy company shares at a fixed price later on, often below future market value. They matter to investors because they align employee incentives with company performance, can dilute existing ownership when exercised, and create potential tax advantages for option holders if certain holding-time rules are met — think of them as a coupon to buy stock at today’s price with extra tax rules attached.
2022 Stock Incentive Plan financial
"awards of restricted stock and incentive stock options pursuant to the Company’s 2022 Stock Incentive Plan"
emerging growth company regulatory
"Emerging growth company o Item 5.02. Departure of directors or certain officers;"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
named executive officer financial
"each named executive officer’s base salary was increased by 3% as follows"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
FALSE000153743500015374352024-05-092024-05-09


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________________
 
FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 26, 2026


TECOGEN INC.
(Exact Name of Registrant as Specified in Charter)

Delaware
(State or Other Jurisdiction of Incorporation)
001-36103 04-3536131
(Commission File Number) (IRS Employer Identification No.)
76 Treble Cove Road, Building 1
North Billerica, Massachusetts 01862
(Address of Principal Executive Offices and Zip Code)
(781) 466-6400
(Registrant's telephone number, including area code)
 
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each classTrading SymbolName of exchange on which registered
Common Stock, $0.001 par value per shareTGENNYSE American, LLC
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o




Item 5.02. Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.

On June 26, 2026, the Compensation Committee of Tecogen Inc. (the “Company”) recommended to the Company’s Board of Directors that in order to align the economic interests of the Company’s Chief Executive Officer, Abinand Rangesh, and its other named executive officers with the interests of the Company and its stockholders, the Company grant to them the following awards of restricted stock and incentive stock options pursuant to the Company’s 2022 Stock Incentive Plan. The Company’s Board of Directors approved such awards at a meeting held on June 26, 2026.

Named Executive OfficerEquity Grant
Number of Shares of Restricted Stock or Shares Underlying Options
Abinand Rangesh, CEORestricted Stock Award 174,081
Incentive Stock Option26,041
Robert A. Panora, President and COORestricted Stock Award9,671
Incentive Stock Option26,041
Roger Deschenes, CFORestricted Stock Award29,013
Stephen Lafaille, VP of Business DevelopmentRestricted Stock Award29,013
John K. Whiting, IV, General Counsel & SecretaryRestricted Stock Award19,342

Each of such awards vests in equal installments on the first, second, third, and fourth anniversaries of the date of grant. The incentive stock options are exercisable at a price of $5.17 per share.

In addition, the Compensation Committee also recommended to the Board, and the Board approved at the above referenced meeting, increases in the cash compensation payable to Mr. Rangesh and each named executive officer. Mr. Rangesh’s annual base salary was increased by 5% to $220,500; and each named executive officer’s base salary was increased by 3% as follows: Mr. Panora’s annual base salary was increased to $206,000; Mr. Deschenes’ annual base salary was increased to $185,400; Mr. Lafaille’s annual base salary was increased to $152,260; and Mr. Whiting’s annual base salary was increased to $185,400.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
TECOGEN INC.
By: /s/ Abinand Rangesh
July 1, 2026Abinand Rangesh, Chief Executive Officer
Principal Executive Officer

Source: View Original Filing on SEC EDGAR

FAQ

What executive compensation changes did Tecogen (TGEN) approve on June 26, 2026?

Tecogen approved new equity awards and salary increases for its CEO and other named executives. The package includes restricted stock, incentive stock options vesting over four years, and base salary raises of 5% for the CEO and 3% for other officers.

How many Tecogen (TGEN) shares were granted to CEO Abinand Rangesh?

CEO Abinand Rangesh received 174,081 shares of restricted stock and incentive stock options on 26,041 shares. These awards vest in four equal annual installments and are intended to align his compensation more closely with long-term shareholder interests.

What is the exercise price of Tecogen (TGEN) incentive stock options granted in June 2026?

The incentive stock options granted to Tecogen’s executives are exercisable at $5.17 per share. These options vest in four equal installments on the first through fourth anniversaries of the grant date, rewarding continued service and potential future share price appreciation.

How did Tecogen (TGEN) change CEO Abinand Rangesh’s base salary?

Tecogen increased CEO Abinand Rangesh’s annual base salary by 5% to $220,500. This adjustment is part of a broader package of equity and cash compensation changes designed to align leadership incentives with company and shareholder interests.

What base salary increases did other Tecogen (TGEN) executives receive?

Each named executive officer other than the CEO received a 3% base salary increase. New annual salaries are $206,000 for the President and COO, $185,400 for the CFO and General Counsel, and $152,260 for the VP of Business Development.

Which Tecogen (TGEN) executives received restricted stock or options in June 2026?

Awards went to CEO Abinand Rangesh, President and COO Robert A. Panora, CFO Roger Deschenes, VP of Business Development Stephen Lafaille, and General Counsel John K. Whiting. Grants included restricted stock for all and stock options for Rangesh and Panora.

Filing Exhibits & Attachments

3 documents

Other Documents